CAS 865-48-5 - China Manufacturers, Suppliers, Factory

CAS 865-48-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%
Read More

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.08.24 19:03:32
2022.08.20 14:47:01
2022.03.10 18:06:46
2022.02.10 20:40:59
2022.01.23 15:39:04
2021.12.24 10:10:07

CAS 865-48-5 - China Manufacturers, Suppliers, Factory

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

3-Methyl-2-Butanol CAS 598-75-4 Purity ≥99.0% (GC)

Bis(2,6-Diisopropylphenyl)carbodiimide CAS 2162-74-5 (Stabilizer 7000) Purity >98.0% (GC)

4,6-Dihydroxy-2-Methylthiopyrimidine CAS 1979-98-2 Assay ≥98.0% (HPLC) Factory Hot Sale

4-Bromo-1-Methylpyrazole CAS 15803-02-8 Purity >99.0% (GC) Factory

Methyl Acetoacetate (MAA) CAS 105-45-3 Purity >99.0% (GC) Factory

(R)-(+)-Glycidol CAS 57044-25-4 Chemical Purity ≥99.0% Chiral Purity ≥99.0% e.e (GC) Factory High Quality

Boc-Met-OH CAS 2488-15-5 Purity >99.0% (HPLC) Factory

5-Methylcytidine CAS 2140-61-6 Purity ≥99.0% (HPLC)

Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

4,4,4-Trifluoro-1-(p-Tolyl)-1,3-Butanedione CAS 720-94-5 Celecoxib Intermediate Purity >99.0% (GC)

Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8 Purity >98.0% (GC) Telmisartan Intermediate

Fischer's Aldehyde CAS 84-83-3 Purity >99.0% (HPLC) Factory High Quality

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Xi presents award to top scientists

Yellow phosphorus and phosphoric acid rose together

New COVID treatments offer hope

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.08.24 19:03:32

2022.08.20 14:47:01

2022.03.10 18:06:46

2022.02.10 20:40:59

2022.01.23 15:39:04

2021.12.24 10:10:07

related search